Iulia Diaconu

3.3k total citations
37 papers, 2.0k citations indexed

About

Iulia Diaconu is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Iulia Diaconu has authored 37 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 21 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Iulia Diaconu's work include Virus-based gene therapy research (26 papers), CAR-T cell therapy research (21 papers) and Cancer Research and Treatments (9 papers). Iulia Diaconu is often cited by papers focused on Virus-based gene therapy research (26 papers), CAR-T cell therapy research (21 papers) and Cancer Research and Treatments (9 papers). Iulia Diaconu collaborates with scholars based in Finland, United States and Romania. Iulia Diaconu's co-authors include Vincenzo Cerullo, Akseli Hemminki, Gianpietro Dotti, Barbara Savoldo, Anna Kanerva, Ignazio Caruana, Saila K. Pesonen, Sari Pesonen, Mari Hirvinen and Sophie Escutenaire and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Iulia Diaconu

37 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iulia Diaconu Finland 25 1.3k 1.3k 901 504 308 37 2.0k
Siri Tähtinen Finland 20 1.0k 0.8× 837 0.7× 670 0.7× 564 1.1× 226 0.7× 32 1.6k
Frederick J. Kohlhapp United States 14 1.3k 1.0× 1.1k 0.9× 919 1.0× 814 1.6× 260 0.8× 27 2.3k
Philippe Erbs France 21 586 0.4× 894 0.7× 629 0.7× 196 0.4× 239 0.8× 52 1.4k
Sònia Guedan Spain 22 3.6k 2.8× 1.5k 1.2× 1.5k 1.7× 1.4k 2.8× 232 0.8× 40 4.2k
Kerry D. Fisher United Kingdom 27 867 0.7× 1.4k 1.1× 1.2k 1.4× 173 0.3× 273 0.9× 53 2.0k
Xiao‐Tong Song United States 17 1.0k 0.8× 391 0.3× 491 0.5× 644 1.3× 77 0.3× 47 1.5k
David DiGiusto United States 20 1.3k 1.0× 766 0.6× 1.2k 1.3× 1.0k 2.0× 33 0.1× 49 2.8k
Boris Engels United States 21 1.2k 0.9× 480 0.4× 387 0.4× 886 1.8× 104 0.3× 36 1.6k
Holly M. Horton United States 20 591 0.5× 222 0.2× 836 0.9× 668 1.3× 111 0.4× 48 1.8k
Laura Evgin United States 16 639 0.5× 646 0.5× 378 0.4× 261 0.5× 121 0.4× 28 987

Countries citing papers authored by Iulia Diaconu

Since Specialization
Citations

This map shows the geographic impact of Iulia Diaconu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iulia Diaconu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iulia Diaconu more than expected).

Fields of papers citing papers by Iulia Diaconu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iulia Diaconu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iulia Diaconu. The network helps show where Iulia Diaconu may publish in the future.

Co-authorship network of co-authors of Iulia Diaconu

This figure shows the co-authorship network connecting the top 25 collaborators of Iulia Diaconu. A scholar is included among the top collaborators of Iulia Diaconu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iulia Diaconu. Iulia Diaconu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Diaconu, Iulia, Brandon Ballard, Ming Zhang, et al.. (2017). Inducible Caspase-9 Selectively Modulates the Toxicities of CD19-Specific Chimeric Antigen Receptor-Modified T Cells. Molecular Therapy. 25(3). 580–592. 208 indexed citations
3.
Liikanen, Ilkka, Juuso Juhila, Riku Turkki, et al.. (2015). Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus. Molecular Therapy. 24(1). 175–183. 25 indexed citations
4.
Nishio, Nobuhiro, Iulia Diaconu, Hao Liu, et al.. (2014). Armed Oncolytic Virus Enhances Immune Functions of Chimeric Antigen Receptor–Modified T Cells in Solid Tumors. Cancer Research. 74(18). 5195–5205. 272 indexed citations
5.
Caruana, Ignazio, Iulia Diaconu, & Gianpietro Dotti. (2014). From Monoclonal Antibodies to Chimeric Antigen Receptors for the Treatment of Human Malignancies. Seminars in Oncology. 41(5). 661–666. 33 indexed citations
6.
Kanerva, Anna, Petri Nokisalmi, Iulia Diaconu, et al.. (2013). Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus. Clinical Cancer Research. 19(10). 2734–2744. 144 indexed citations
7.
Liikanen, Ilkka, Laura Ahtiainen, Mari Hirvinen, et al.. (2013). Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients. Molecular Therapy. 21(6). 1212–1223. 139 indexed citations
8.
Parviainen, Suvi, Iulia Diaconu, Mari Hirvinen, et al.. (2013). CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging. Gene Therapy. 21(2). 195–204. 34 indexed citations
9.
Diaconu, Iulia, Vincenzo Cerullo, Mari Hirvinen, et al.. (2012). Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus. Cancer Research. 72(9). 2327–2338. 136 indexed citations
10.
Pesonen, Sari, Iulia Diaconu, Lotta Kangasniemi, et al.. (2012). Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients. Cancer Research. 72(7). 1621–1631. 107 indexed citations
11.
Hemminki, Otto, Iulia Diaconu, Vincenzo Cerullo, et al.. (2012). Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer. Molecular Therapy. 20(9). 1821–1830. 62 indexed citations
12.
Rajecki, Maria, Mirkka Sarparanta, Tanja Hakkarainen, et al.. (2012). SPECT/CT Imaging of hNIS -Expression after Intravenous Delivery of an Oncolytic Adenovirus and 131I. PLoS ONE. 7(3). e32871–e32871. 21 indexed citations
13.
Cerullo, Vincenzo, Iulia Diaconu, Valentina Romano, et al.. (2012). An Oncolytic Adenovirus Enhanced for Toll-like Receptor 9 Stimulation Increases Antitumor Immune Responses and Tumor Clearance. Molecular Therapy. 20(11). 2076–2086. 81 indexed citations
14.
Liikanen, Ilkka, Vladia Monsurrò, Laura Ahtiainen, et al.. (2011). Induction of Interferon Pathways Mediates In Vivo Resistance to Oncolytic Adenovirus. Molecular Therapy. 19(10). 1858–1866. 39 indexed citations
15.
Escutenaire, Sophie, Vincenzo Cerullo, Iulia Diaconu, et al.. (2011). In vivoandin vitrodistribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartments. Annals of Medicine. 43(2). 151–163. 18 indexed citations
16.
Dias, João D., Ilkka Liikanen, Kilian Guse, et al.. (2010). Targeted Chemotherapy for Head and Neck Cancer with a Chimeric Oncolytic Adenovirus Coding for Bifunctional Suicide Protein FCU1. Clinical Cancer Research. 16(9). 2540–2549. 36 indexed citations
17.
Ahtiainen, Laura, Cristina Mirantes, Tiina Jahkola, et al.. (2010). Defects in Innate Immunity Render Breast Cancer Initiating Cells Permissive to Oncolytic Adenovirus. PLoS ONE. 5(11). e13859–e13859. 27 indexed citations
18.
Diaconu, Iulia, Sari Pesonen, Anna Kanerva, et al.. (2010). Calcium Gluconate in Phosphate Buffered Saline Increases Gene Delivery with Adenovirus Type 5. PLoS ONE. 5(9). e13103–e13103. 1 indexed citations
19.
Dias, João D., Kilian Guse, Petri Nokisalmi, et al.. (2009). Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures. European Journal of Cancer. 46(3). 625–635. 25 indexed citations
20.
Vlad, Anda, Iulia Diaconu, & Kira R. Gantt. (2006). MUC1 in Endometriosis and Ovarian Cancer. Immunologic Research. 36(1-3). 229–236. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Siri Tähtinen Breakdown of academic impact, for papers by Frederick J. Kohlhapp Breakdown of academic impact, for papers by Philippe Erbs Breakdown of academic impact, for papers by Sònia Guedan Breakdown of academic impact, for papers by Kerry D. Fisher Breakdown of academic impact, for papers by Xiao‐Tong Song Breakdown of academic impact, for papers by David DiGiusto Breakdown of academic impact, for papers by Boris Engels Breakdown of academic impact, for papers by Holly M. Horton Breakdown of academic impact, for papers by Laura Evgin
Rankless by CCL
2026